Studies presented at Obesity Week 2025 validate the test’s ability to predict weight-loss response to GLP-1 drugs like semaglutide, including in diverse patient populations and post-bariatric surgery patients.
In this episode of Causes or Cures, Dr. Eeks chats with Dr. Andres Acosta MD PHD about the identification of 4 phenotypes for obesity and how they can revolutionize the future of obesity treatment.
